Clinical trial
Phase 0 Monitoring of Gluten-free Diet Compliance in Celiac Patients by Assessment of Gliadin 33-mer Equivalent Epitopes in Feces
NCT01478867 is registered in ClinicalTrials.gov with University of Seville as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 0 Monitoring of Gluten-free Diet Compliance in Celiac Patients by Assessment of Gliadin 33-mer Equivalent Epitopes in Feces
- Lead sponsor
- University of Seville
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- July 31, 2011
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.